Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio To Provide Custom Bioinformatics Platform for ACE BioSciences

NEW YORK (GenomeWeb News) – ACE BioSciences has tapped CLC Bio to develop a customized bioinformatics platform that will support its work in vaccine target discovery and validation, CLC Bio said today.
 
Under the terms of the agreement, CLC Bio will upgrade ACE BioSciences' current bioinformatics platform to ensure that the firm can compare, rank, and prioritize potential vaccine targets.
 
The solution will include several of CLC Bio’s workbenches for DNA, RNA, and protein sequence analysis, as well as customized modules that will be proprietary for ACE BioSciences
 
Financial terms of the agreement were not provided.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.